Viral and non-viral nanoplasmid vectors with improved production
AssigneeAldevron, LLC
InventorJames A. Williams
Life of this patent
Estimating the term…
Loading patent…
AssigneeAldevron, LLC
InventorJames A. Williams
Estimating the term…
A method for improving the replication of a covalently closed circular plasmid is provided. The method includes providing a covalently closed circular plasmid having a Pol I-dependent origin of replication, and an insert including a structured DNA sequence selected from the group consisting of inverted repeat sequence, direct repeat sequence, homopolymeric repeat sequence, eukaryotic origin of replication or eukaryotic promoter enhancer sequence, wherein the structured DNA sequence is located at a distance of less than 1000 bp from the Pol I-dependent origin of replication in the direction of replication. The method also includes modifying the covalently closed circular recombinant molecule such that the Pol I-dependent origin of replication is replaced with a Pol III-dependent origin of replication, whereby the resultant Pol III-dependent origin of replication covalently closed circular plasmid has improved replication. An antibiotic marker free covalently closed circular recombinant DNA molecule is also provided.
1-18. (canceled)
An engineered E. coli cell comprising one or more copies of a chromosomally-integrated arabinose-inducible CI857ts gene.
25-36. (canceled)
Dependencies are inferred from the claim text.